Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

被引:116
作者
Bandres-Ciga, Sara [1 ,2 ]
Noyce, Alastair J. [3 ,4 ]
Hemani, Gibran [5 ]
Nicolas, Aude [6 ]
Calvo, Andrea [7 ]
Mora, Gabriele [8 ]
Tienari, Pentti J. [9 ]
Stone, David J. [10 ]
Nalls, Mike A. [1 ,11 ]
Singleton, Andrew B. [1 ]
Chio, Adriano [7 ,12 ,13 ]
Traynor, Bryan J. [6 ,14 ]
机构
[1] NIH, Mol Genet Sect, Lab Neurogenet, Natl Inst Aging, Bldg 10, Bethesda, MD 20892 USA
[2] Inst Invest Biosanitaria Granada ibsGRANADA, Granada, Spain
[3] Queen Mary Univ London, Wolfson Inst Prevent Med, Prevent Neurol Unit, London, England
[4] UCL, Inst Neurol, Dept Clin & Movement Neurosci, London, England
[5] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England
[6] NIH, Neuromuscular Dis Res Sect, Sect Lab Neurogenet, Natl Inst Aging, Bldg 10, Bethesda, MD 20892 USA
[7] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy
[8] IRCCS, ALS Ctr, Ist Clin Scientif Maugeri, Milan, Italy
[9] Univ Helsinki, Helsinki Univ Hosp & Mol Neurol Programme, Biomed, Dept Neurol, Helsinki, Finland
[10] Merck Res Labs Merck & Co Inc, Genet & Pharmacogen, West Point, PA USA
[11] Data Tecn Int, Glen Echo, MD USA
[12] CNR, Inst Cognit Sci & Technol, Rome, Italy
[13] Azienda Ospedaliero Univ Citta Salute & Sci, Turin, Italy
[14] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA
基金
英国惠康基金;
关键词
LD SCORE REGRESSION; MENDELIAN RANDOMIZATION; CHOLESTEROL HOMEOSTASIS; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; PROTECTIVE FACTOR; DYSLIPIDEMIA; BIAS;
D O I
10.1002/ana.25431
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To identify shared polygenic risk and causal associations in amyotrophic lateral sclerosis (ALS). Methods Linkage disequilibrium score regression and Mendelian randomization were applied in a large-scale, data-driven manner to explore genetic correlations and causal relationships between >700 phenotypic traits and ALS. Exposures consisted of publicly available genome-wide association studies (GWASes) summary statistics from MR Base and LD-hub. The outcome data came from the recently published ALS GWAS involving 20,806 cases and 59,804 controls. Multivariate analyses, genetic risk profiling, and Bayesian colocalization analyses were also performed. Results We have shown, by linkage disequilibrium score regression, that ALS shares polygenic risk genetic factors with a number of traits and conditions, including positive correlations with smoking status and moderate levels of physical activity, and negative correlations with higher cognitive performance, higher educational attainment, and light levels of physical activity. Using Mendelian randomization, we found evidence that hyperlipidemia is a causal risk factor for ALS and localized putative functional signals within loci of interest. Interpretation Here, we have developed a public resource () which we hope will become a valuable tool for the ALS community, and that will be expanded and updated as new data become available. Shared polygenic risk exists between ALS and educational attainment, physical activity, smoking, and tenseness/restlessness. We also found evidence that elevated low-desnity lipoprotein cholesterol is a causal risk factor for ALS. Future randomized controlled trials should be considered as a proof of causality. Ann Neurol 2019;85:470-481
引用
收藏
页码:470 / 481
页数:12
相关论文
共 50 条
  • [41] Alzheimer disease pathology in amyotrophic lateral sclerosis
    Ronald L. Hamilton
    Robert Bowser
    Acta Neuropathologica, 2004, 107 : 515 - 522
  • [42] Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?
    Bhutani, Himshikha
    Anand, Akshay
    CURRENT NEUROVASCULAR RESEARCH, 2012, 9 (04) : 302 - 309
  • [43] Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
    Ferrara, Deborah
    Pasetto, Laura
    Bonetto, Valentina
    Basso, Manuela
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [44] Disorders of emotional processing in amyotrophic lateral sclerosis
    Sedda, Anna
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (06) : 659 - 665
  • [45] An Overview of DNA Repair in Amyotrophic Lateral Sclerosis
    Coppede, Fabio
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 1679 - 1691
  • [46] Drug repurposing in amyotrophic lateral sclerosis (ALS)
    Carroll, Emily
    Scaber, Jakub
    Huber, Kilian V. M.
    Brennan, Paul E.
    Thompson, Alexander G.
    Turner, Martin R.
    Talbot, Kevin
    EXPERT OPINION ON DRUG DISCOVERY, 2025, : 447 - 464
  • [47] A causal association between amyotrophic lateral sclerosis and atrial fibrillation: a two-sample Mendelian randomization study
    Yao, Yiren
    Liu, Hongyang
    Gu, Yang
    Xu, Xiaojin
    Zhang, Xiwen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [48] Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study
    Liu, Bin
    Lyu, Linshuoshuo
    Zhou, Wenkai
    Song, Jie
    Ye, Ding
    Mao, Yingying
    Chen, Guo-Bo
    Sun, Xiaohui
    BMC MEDICINE, 2023, 21 (01)
  • [49] Dietary factors and risk for amyotrophic lateral sclerosis: A two sample mendelian randomization study
    Jing, Zhaoyi
    Qi, Xianghua
    Teng, Jing
    MEDICINE, 2024, 103 (25)
  • [50] Amyotrophic Lateral Sclerosis and Risk of Common Cancer: Mendelian Randomization Interrogation of Causality and Mediation
    Tan, Xiaoxue
    Liu, Gaifen
    Li, Xiangnan
    Zhong, Fan
    Su, Zhixi
    Wang, Haijian
    PHENOMICS, 2025,